Try
Medpace Holdings Inc.
MEDPUnited States
79 filed reports · 451 financial concepts · 2 earnings calls · 0 media appearances
Filed reports
79 reports · Sep 2016 to Jun 2026Each report counts once it has at least one extracted financial fact. Also extracted from these reports: 330 guidance figures.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Current · 8-KSEC EDGAR | 39 | 338 | Sep 2016 to Jun 2026 |
| Quarterly · 10-QSEC EDGAR | 30 | 4,639 | Sep 2016 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 10 | 4,667 | Dec 2016 to Dec 2025 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Jul 23, 2026 | 336 | Open |
| FY2026 Q2 | 8-K | Jun 30, 2026 | Jul 22, 2026 | 10 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | Apr 23, 2026 | 209 | Open |
| FY2026 Q1 | 8-K | Mar 31, 2026 | Apr 22, 2026 | 10 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Feb 10, 2026 | 918 | Open |
| FY2025 Q4 | 8-K | Dec 31, 2025 | Feb 9, 2026 | 8 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Oct 23, 2025 | 233 | Open |
| FY2025 Q3 | 8-K | Sep 30, 2025 | Oct 22, 2025 | 10 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Jul 22, 2025 | 142 | Open |
| FY2025 Q2 | 8-K | Jun 30, 2025 | Jul 21, 2025 | 10 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | Apr 22, 2025 | 147 | Open |
| FY2025 Q1 | 8-K | Mar 31, 2025 | Apr 21, 2025 | 8 | Open |
Financial data
451 concepts · 9,644 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial422 concepts · 8,597 facts · Dec 2011 to Jul 2026
- Net income loss57 · Mar 2015 to Jun 2026
- Operating income loss57 · Mar 2015 to Jun 2026
- Revenue57 · Mar 2015 to Jun 2026
- Amortization of intangible assets55 · Sep 2015 to Jun 2026
- Cash and cash equivalents at carrying value55 · Dec 2014 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents55 · Dec 2014 to Jun 2026
- Comprehensive income net of tax55 · Sep 2015 to Jun 2026
- Costs and expenses55 · Sep 2015 to Jun 2026
- Depreciation55 · Sep 2015 to Jun 2026
- Income tax expense benefit55 · Sep 2015 to Jun 2026
- Interest income expense nonoperating net55 · Sep 2015 to Jun 2026
- Nonoperating income expense55 · Sep 2015 to Jun 2026
- Other comprehensive income loss foreign currency transaction and translation adjustment net of tax55 · Sep 2015 to Jun 2026
- Other nonoperating income expense55 · Sep 2015 to Jun 2026
- Selling general and administrative expense55 · Sep 2015 to Jun 2026
- Allowance for doubtful accounts receivable current54 · Dec 2014 to Jun 2026
- Deferred income tax expense benefit54 · Dec 2015 to Jun 2026
- Goodwill (US GAAP)54 · Dec 2014 to Jun 2026
- Increase decrease in accounts payable54 · Dec 2015 to Jun 2026
- Increase decrease in accrued liabilities54 · Dec 2015 to Jun 2026
- Increase decrease in other operating capital net54 · Dec 2015 to Jun 2026
- Increase decrease in prepaid deferred expense and other assets54 · Dec 2015 to Jun 2026
- Increase decrease in receivables54 · Dec 2015 to Jun 2026
- Other noncash income expense54 · Dec 2015 to Jun 2026
Product3 concepts · 425 facts · Dec 2016 to Jun 2026
- Revenue323 · Dec 2016 to Jun 2026
- Direct operating costs68 · Dec 2018 to Jun 2026
- Revenue from related parties34 · Dec 2016 to Jun 2022
Guidance10 concepts · 338 facts · Nov 2016 to Jul 2026
- Revenue Guidance84 · Nov 2016 to Jul 2026
- EPS (Diluted) Guidance78 · Nov 2016 to Jul 2026
- Net Income Guidance78 · Nov 2016 to Jul 2026
- Effective Tax Rate Guidance66 · May 2017 to Jul 2026
- Revenue Growth Guidance18 · Nov 2016 to Jul 2026
- EPS (Diluted) Guidance (Adjusted (non-GAAP))4 · Nov 2016 to Jul 2017
- Net Income Guidance (Adjusted (non-GAAP))4 · Nov 2016 to Jul 2017
- Operating Income Guidance (Adjusted (non-GAAP))2 · Jul 2017
- Revenue Growth Guidance (net service revenue)2 · Jul 2017
- Revenue Guidance (net service revenue)2 · Jul 2017
Segment15 concepts · 222 facts · Dec 2022 to Jun 2026
- Direct operating costs28 · Dec 2022 to Jun 2026
- Amortization of intangible assets14 · Dec 2022 to Jun 2026
- Costs and expenses14 · Dec 2022 to Jun 2026
- Depreciation14 · Dec 2022 to Jun 2026
- Income tax expense benefit14 · Dec 2022 to Jun 2026
- Interest income expense nonoperating net14 · Dec 2022 to Jun 2026
- Labor and related expense14 · Dec 2022 to Jun 2026
- Net income loss14 · Dec 2022 to Jun 2026
- Nonoperating income expense14 · Dec 2022 to Jun 2026
- Operating income loss14 · Dec 2022 to Jun 2026
- Other nonoperating income expense14 · Dec 2022 to Jun 2026
- Revenue14 · Dec 2022 to Jun 2026
- Segment reporting other item amount14 · Dec 2022 to Jun 2026
- Selling general and administrative expense14 · Dec 2022 to Jun 2026
- Income loss from continuing operations before income taxes extraordinary items noncontrolling interest12 · Dec 2022 to Jun 2026
Geography1 concepts · 62 facts · Dec 2015 to Dec 2025
- Property, Plant & Equipment, Net62 · Dec 2015 to Dec 2025
Segments
709 factsFigures broken down by business line, region, product or another axis the company reports on.
Product or servicesrt:ProductOrServiceAxis14 members · 417 facts
- Revenue Net50 · Dec 2016 to Dec 2023
- Antiviral And Anti Infective42 · Mar 2018 to Jun 2026
- Cardiology42 · Mar 2018 to Jun 2026
- Central Nervous System42 · Mar 2018 to Jun 2026
- Metabolic42 · Mar 2018 to Jun 2026
- Oncology42 · Mar 2018 to Jun 2026
- Other42 · Mar 2018 to Jun 2026
- Direct Costs34 · Dec 2018 to Jun 2026
- Reimbursable Out Of Pocket Costs34 · Dec 2018 to Jun 2026
- Direct Revenue15 · Dec 2016 to Dec 2019
- Reimbursed Out Of Pocket Revenue15 · Dec 2016 to Dec 2019
- Medical Devices7 · Mar 2018 to Jun 2019
- Service6 · Jun 2017 to Sep 2018
- Endocrine4 · Jun 2018 to Dec 2018
Statement business segments1 member · 222 facts
- Reportable222 · Dec 2022 to Jun 2026
Statement geographicalus-gaap:StatementGeographicalAxis5 members · 55 facts
- Be11 · Dec 2015 to Dec 2025
- Us11 · Dec 2015 to Dec 2025
- Other countries11 · Dec 2015 to Dec 2025
- Other europe countries11 · Dec 2015 to Dec 2025
- Europe11 · Dec 2015 to Dec 2025
Product or serviceus-gaap:ProductOrServiceAxis8 members · 8 facts
- Antiviral And Anti Infective1 · Mar 2018
- Cardiology1 · Mar 2018
- Central Nervous System1 · Mar 2018
- Endocrine1 · Mar 2018
- Medical Devices1 · Mar 2018
- Metabolic1 · Mar 2018
- Oncology1 · Mar 2018
- Other1 · Mar 2018
Statement geographicalsrt:StatementGeographicalAxis1 member · 7 facts
- Asia pacific7 · Dec 2018 to Dec 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
- Earnings-release commentary22 claims from 8 reports · Sep 2024 to Jun 2026
- Management discussion (MD&A) commentary143 claims from 8 reports · Sep 2024 to Jun 2026
- Risk factors40 risks from 2 annual reports · 2024 to 2025
Earnings calls
2 calls · Apr 2026 to Jul 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Jul 22, 2026
- FY2026 Q1Apr 22, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 17, 2026) and refreshed every few hours.